NCT04244201

Vaporous Hyperoxia Therapy (VHT) in the Treatment of Foot Wounds

Evaluation of Vaporous Hyperoxia Therapy (VHT) for Chronic Wounds

• Status: Completed
• Phase: N/A
• Study type: Interventional
• Enrollment: 31 (actual)
• Sponsor: Vaporox · Industry
• Sex: All
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

The purpose of this study is to evaluate the effectiveness of Vaporous Hyperoxia Therapy (VHT), previously named Misty (WTS-1000) for the treatment of chronic foot ulcers.

Detailed description

The Vaporox VHT1 study is a single arm study evaluating the efficacy of Vaporous Hyperoxia Therapy (VHT), previously named Misty (WTS-1000), as an adjunctive therapy for the treatment of chronic foot ulcers.

Conditions

• Neuropathic Foot Ulcer
• Foot Ulcer

Interventions

Type	Name	Description
DEVICE	Vaporous Hyperoxia Therapy	1 hour of treatment, 4 times per week

Timeline

• Start date: 2005-06-06
• Primary completion: 2007-03-01
• Completion: 2007-10-04
• First posted: 2020-01-28
• Last updated: 2020-01-30

Regulatory

• FDA-regulated device study